NOCTURNE GMBH
Desconocido
CLAIMS: CLinical impact through AI-assisted MS care
NOCTURNE GMBH
participó en un
HORIZON EUROPE:
HORIZON-JU-IHI-2022-01-single-stage
Multiple sclerosis (MS) is a devastating immune-mediated disorder of the central nervous system. Since there is no cure available yet for MS...
2023-05-15 - 2027-05-31 | Financiado
2023-05-15 - 2027-05-31 | Financiado
NeuroRetina: The eye as a window to the brain
NOCTURNE GMBH
tramitó un
HORIZON EUROPE:
HORIZON-EIE-2021-SCALEUP-01
Nocturne GmbH, founded in 2018, is a spin-off from the Charité – Universitätsmedizin Berlin, Germany developing software solutions to effici...
2022-05-24 - 2022-11-30 | Financiado
2022-05-24 - 2022-11-30 | Financiado
Nocturne: The eye as a window to the brain extending lifelong brain health
NOCTURNE GMBH
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
Nocturne specializes in products and services that allow diagnosing neurologic disorders through imaging of the eye. Nocturne’s proprietary...
2019-05-06 - 2019-11-30 | Financiado
2019-05-06 - 2019-11-30 | Financiado
* No se disponen de datos de la empresa actual.